SEC Form 4 · accession 0000874015-18-000113
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter N Reikes
Director
Period of report
Sep 23, 2018
Accepted (ET)
Sep 24, 2018 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $49.14 | Sep 23, 2018 | A | 32,000 | A | Sep 23, 2019 | Sep 22, 2028 | Common Stock | 32,000 | 32,000 | D |
Explanation of responses
- F1Grant of September 23, 2018 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on September 23, 2019. The option shall be fully vested and exercisable on September 23, 2022. The option is exercisable to 0 shares on September 23, 2018.